Faculty of 1000 evaluation for NOA-04 randomized phase III trial of sequential radiochemotherapy of anaplastic glioma with procarbazine, lomustine, and vincristine or temozolomide.

Andrea Pace, Cherubino Di Lorenzo
  • Faculty of 1000, Ltd.
  • DOI: 10.3410/f.1168400.630580
The author haven't finished explaining this publicationThe author haven't finished explaining this publication

The following have contributed to this page: Dr Cherubino Di Lorenzo